ValidBMTI: Using a New Calibrated Tool in Specific Language and Learning Disorders : the BMTi

Sponsor
Centre Hospitalier Intercommunal Creteil (Other)
Overall Status
Completed
CT.gov ID
NCT03919357
Collaborator
Association pour la recherche des troubles de l'apprentissage (Other), Orthoédition (Other), Association Française de Pédiatrie Ambulatoire- AFPA (Other), Association pour l'Etude du Développement de l'Enfant (Other)
229
16
24.8
14.3
0.6

Study Details

Study Description

Brief Summary

The group of experts at HAS has defined the places of first and second-line workers in specific disorders of development and learning, as defined in the international diagnostic classifications International Classification of Diseases (CIM) CIM 11 and Diagnostic and Statistical Manual of Mental Disorders (DSM) DSM 5. The referral to a second-level structure, a multidisciplinary structure in charge of carrying out the different cognitive assessments, requires a preliminary evaluation.

This orientation is based on a medical consultation, carried out by a doctor specialized in the field, with an exploration tool adapted to the different fields concerned.

The BMTi, a battery of third-generation tests (after the Rapid battery of evaluation of the cognitive functions (BREV) and then the Evaluation of cognitive functions and learning of the child (EDA)) will enable the doctor, from 2018, to carry out this orientation in a relevant way in response to children with a complaint about neurodevelopment and learning. .

The research project aims to validate this hypothesis, by comparing the diagnoses posed in a conventional way with the various multidisciplinary assessments, with the results of the transfer of all or part of the subtests of the BMTi by a doctor of second resort.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: BMT-i

Detailed Description

The group of experts at High Authority of Health (HAS) has defined the places of first and second-line workers in specific disorders of development and learning, as defined in the international diagnostic classifications CIM 11 and DSM 5. The referral to a second-level structure, a multidisciplinary structure in charge of carrying out the different cognitive assessments, requires a preliminary evaluation.

This orientation is based on a medical consultation, carried out by a doctor specialized in the field, with an exploration tool adapted to the different fields concerned.

The BMTi, a battery of third-generation tests (after the BREV and then the EDA) will enable the doctor, from 2018, to carry out this orientation in a relevant way in response to children with a complaint about neurodevelopment and learning. .

The research project aims to validate this hypothesis, by comparing the diagnoses posed in a conventional way with the various multidisciplinary assessments, with the results of the transfer of all or part of the subtests of the BMTi by a doctor of second resort.

This research project finds its place in a more global approach for a complete application of the recommendations of the group of experts of the High Authority of Health with:

  • the systematic evaluation of educational prevention strategies by intensive training in small groups of children with similar needs, in schools,

  • the evaluation of the role of the primary care physician in the prescription of the initial investigation report in the face of a simple reading, writing or numeracy disorder (research project with letter of intent filed in the framework of the call for tenders 38/5000 general direction of the offer of care (DGOS) PREPS 2018),

  • the current project to validate referral tools to second-level appraisals,

  • an evaluation project of the financing modalities filed under the regional health agency "Occitanie" in the framework of the call for tenders of article 51,

  • the introduction of training courses for the first and second-line tools for ambulatory doctors.

Study Design

Study Type:
Observational
Actual Enrollment :
229 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of the Diagnostic Approach to Specific Language Disorders and Learning Using a New Calibrated Tool: the Modular Battery Tests Computerized (BMTi)
Actual Study Start Date :
Mar 7, 2019
Actual Primary Completion Date :
Mar 1, 2021
Actual Study Completion Date :
Apr 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Verbal

Passing of a specialized questionnaire on verbal disorders

Behavioral: BMT-i
Passing the BMT-i test

Non-verbal

Passing of a specialized questionnaire on non verbal disorders

Behavioral: BMT-i
Passing the BMT-i test

Attention

Passing of a specialized questionnaire on attention disorders

Behavioral: BMT-i
Passing the BMT-i test

Complaint about learning

Passing of a specialized questionnaire on learning disorders

Behavioral: BMT-i
Passing the BMT-i test

Outcome Measures

Primary Outcome Measures

  1. Sensitivity of BMT-i (modular computerized test battery) [3 months]

    Calculation of the sensitivity of the BMT-i compared to the reference balance sheets

  2. Specificity of BMT-i [3 months]

    Calculation of the specificity of the BMT-i compared to the reference balance sheets

Secondary Outcome Measures

  1. Sensitivity and specificity of the BMT-i by type of complaint [3 months]

    Calculation of the sensitivity and specificity of the BMT-i compared to the reference balance in each type of complaint (oral language, learning, graphics and attention)

  2. Kappa de Cohen test between BMTi assessments and the reference assessments [3 months]

    Assessment of the concordance between the BMTi assessments and the baseline assessments

  3. Concordance between investigators evaluations and reviewers evaluations [3 months]

    Evaluation of the concordance between the BMTi evaluations rated by the investigators and the reviewers

  4. Curves ROC (Receiver operating characteristic) [3 months]

    Receiver operating characteristic (ROC) curves to validate selected BMT-i diagnostic thresholds

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Child aged 5 to 13

  • Complex complaint affecting one of the different areas of development and learning

  • Affiliation to a social security scheme

Exclusion Criteria:
  • Diagnosis of intellectual development disorder of autism spectrum disorder and suspect or confirm

  • Refusal to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cabinet du Dr Vurpillat-Almanza Besançon France
2 Cabinet du Dr Piollet Chamalieres France
3 Cabinet du Dr Gelbert Chambéry France 73000
4 CH Versailles - André Mignot Le Chesnay France
5 Centre Médical Pédiatrique Flammarion Marseille France
6 Hôpital Saint Eloi - Montpellier Montpellier France
7 Cabinet du Dr Kochert Orléans France 45000
8 Centre Paris Santé Réussite Paris France 75020
9 Cabinet du Dr Cahn-Sellem Puteaux France 92800
10 CHU de Rouen Rouen France
11 Cabinet du Dr Reynaud Saint-Denis France
12 Cabinet du Dr Willig Toulouse France
13 Cabinet du Dr Pineau Trélazé France
14 Cabinet du Dr Lubelski Verrières-le-Buisson France
15 Cabinet du Dr Werner Villeneuve les Avignon France
16 Cabinet du Dr Dulorme Le Lamentin Martinique 97129

Sponsors and Collaborators

  • Centre Hospitalier Intercommunal Creteil
  • Association pour la recherche des troubles de l'apprentissage
  • Orthoédition
  • Association Française de Pédiatrie Ambulatoire- AFPA
  • Association pour l'Etude du Développement de l'Enfant

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Intercommunal Creteil
ClinicalTrials.gov Identifier:
NCT03919357
Other Study ID Numbers:
  • ValidBMTI2018
  • 2018-A01870-55
First Posted:
Apr 18, 2019
Last Update Posted:
May 20, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 20, 2021